Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ASKEW, L. J.
Right arrow Articles by CHAO, E. Y.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ASKEW, L. J.
Right arrow Articles by CHAO, E. Y.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1983 British Society for Rheumatology

research-article

OBJECTIVE EVALUATION OF HAND FUNCTION IN SCLERODERMAN PATIENTS TO ASSESS EFFECTIVENESS OF PHYSICAL THERAPY

LINDA J. ASKEW1,, VICTORIA L. BACKETT2, KAI-NAN AN1 and EDMUND Y.S. CHAO1

1Department of Orthopedics, Biomechanical Research Rochester, Minnesota 55905, USA
2Division of Rheumatology and Internal Medicine, Mayo Clinic and Mayo Foundation Rochester, Minnesota 55905, USA

Correspondence to: Address correspondence to Dr. L.J. Askew. c/o Section of Publications, Mayo Clinic, Rochester, MN 55905, USA.

A system was developed to evaluate the hand function of patients with scleroderma objectively in terms of joint contracture, range of movement, dexterity, strength, and skin compliance. Twelve patients with progressive systemic sclerosis were evaluated using this technique to determine the effectiveness of classic physical therapy methods. A statistically significant improvement in hand function was found after a single physical therapy treatment. This conservative mode of treatment may contribute to improved hand function in patients with scleroderma.

KEY WORDS: Scleroderma, Hand function, Physical therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
J. H. Noseworthy, P. C. O'Brien, B. G. Weinshenker, J. A. Weis, T. M. Petterson, B. J. Erickson, A. J. Windebank, J. P. Whisnant, K. A. Stolp-Smith, C. M. Harper Jr., et al.
IV immunoglobulin does not reverse established weakness in MS: A double-blind, placebo-controlled trial
Neurology, October 24, 2000; 55(8): 1135 - 1143.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.